[Vaccination during surveillance stage in children with cancer]

Salud Publica Mex. 2017 Sep-Oct;59(5):500. doi: 10.21149/8589.

[Article in Spanish]

Authors

Jesús Javier Martínez-García^{1

2}, Estela Del Sagrario Velázquez-Gutiérrez¹, Nidia Maribel León-Sicairos^{1

2}, Vicente Adrián Canizalez-Román^{2

3}, Gerardo Alapizco-Castro², Angélica Martínez-Félix³

Affiliations

¹ Departamento de Pediatría, Hospital Pediátrico de Sinaloa Dr. Rigoberto Aguilar Pico. Culiacán, Sinaloa, México.
² Centro de Investigación Aplicada para la Salud Pública, Facultad de Medicina, Universidad Autónoma de Sinaloa. Culiacán, Sinaloa, México.
³ Departamento de Investigación, Hospital de la Mujer. Culiacán, Sinaloa, México.

PMID: 29267636
DOI: 10.21149/8589

No abstract available

Publication types

Letter

MeSH terms

Adolescent
Antineoplastic Agents / therapeutic use*
Child
Female
Humans
Immunocompromised Host
Male
Neoplasms / drug therapy*
Population Surveillance
Surveys and Questionnaires
Vaccination / statistics & numerical data*

Substances

Antineoplastic Agents